Loading clinical trials...
Loading clinical trials...
Evaluation of Peri-Implant Sulcus Fluid Vitamin D and Cathelicidin (LL-37) Levels in Peri-Implant Health and Diseases
Conditions
Interventions
The patients' periodontal clinical parameters were recorded. PISF samples were collected, and the evaluations of 25(OH)D and LL-37 were conducted using enzyme-linked immunosorbent assay.
Locations
1
Turkey (Türkiye)
Altinbas University
Istanbul, BAKIRKOy, Turkey (Türkiye)
Start Date
April 1, 2021
Primary Completion Date
December 1, 2021
Completion Date
December 1, 2021
Last Updated
March 10, 2025
NCT06761521
NCT07104760
NCT06740123
NCT06863116
NCT06619158
NCT06475313
Lead Sponsor
Altinbas University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions